A comprehensive view of Biopharmaceuticals / Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Shinobi Therapeutics, Panasonic, and Kyoto University partner to develop a manufacturing platform to produce iPS-T cell therapies more efficiently and cost-effectively; goal is to aid accessibility of cell therapies globally
Published:
April 19, 2024
by FiercePharma
|
Research by Merck & Co. suggests that in-silico models can help determine design space for cell culture processes, assisting in understanding their operating parameters and limits; study data may improve bioreactor usage
Published:
April 19, 2024
by Chemicals & Chemistry Business Daily
|
Pfizer Applies for Patent on Anti-Proliferative Agents for Treating Pah
Published:
April 19, 2024
by Pharmaceutical Patent News
|
Korean Intellectual Property Office Receives Eli Lilly and Company's Patent Application for Compounds and Methods Targeting Human Tau
Published:
April 19, 2024
by Pharmaceutical Patent News
|
FDA approves Roche's oral Alecensa for ALK-positive early-stage lung cancer treatment following successful Phase 3 trial; trial results show Alecensa reduced the risk of disease recurrence or death by 76%
Published:
April 19, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Ask us about our Bioeconomy market view